Načítá se...
Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
OBJECTIVE: To investigate the effect of enriching mild cognitive impairment (MCI) clinical trials using combined markers of amyloid pathology and neurodegeneration. METHODS: We evaluate an implementation of the recent National Institute for Aging–Alzheimer's Association (NIA-AA) diagnostic crit...
Uloženo v:
| Vydáno v: | Neurology |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035986/ https://ncbi.nlm.nih.gov/pubmed/27558378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003126 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|